Crossmark

Ovarian dysfunction with moderate-dose intravenous cyclophosphamide (modified NIH regimen) and mycophenolate mofetil in young adults with severe lupus: a prospective cohort study

Crossref DOI link: https://doi.org/10.1186/s13075-020-02292-y

Published Online: 2020-08-14

Published Print: 2020-12

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Sharma, Shefali Khanna https://orcid.org/0000-0002-8821-6652
Jain, Siddharth

Bahl, Pooja

Potturi, Pragna

Rathi, Manish

Naidu, Shankar

Sachdeva, Naresh

Dhir, Varun

Jain, Sanjay
License Information

Text and Data Mining valid from 2020-08-14

Version of Record valid from 2020-08-14
More Information

Article History

Received: 24 March 2020

Accepted: 7 August 2020

First Online: 14 August 2020

Ethics approval and consent to participate

: The study was approved by the Institutional Ethics Committee, Postgraduate Institute of Medical Education and Research, Chandigarh, India (Ref No. INT/IEC/2016/2632).

: Taken

: The authors declare that they have no competing interests.

Document is current

Any future updates will be listed below